Sequenom Inc. (SQNM)
Symbol Info
Listed Symbol SQNM
Name Sequenom Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2015-12-31
Latest Fiscal Revenue $128,281,000
Latest Fiscal EPS $-0.15
Price Info
21 Day Moving Average $2.3788
21 Day EMA $2.298470
50 Day Moving Average $1.7794
50 Day EMA $1.965840
200 Day EMA $1.716370
200 Day Moving Average 1.482840
52 Week High $2.53
52 Week Low $0.82
52 Week Change $21.319801
Alpha -0.001789
Beta 1.0606
Standard Deviation 0.261401
R2 0.016917
Periods 60
Share Information
10 Day Average Volume 1,103,432
20 Day Average Volume 1,535,989
30 Day Average Volume 3,260,679
50 Day Average Volume 2,196,412
Outstanding Shares 119,243,357
Float Shares 119,243,357
Percent Float 100.00%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 90
Institute Holdings Date 2016-06-30
Institute Bought Previous 3 Months 2,952,981
Institute Holdings Percent 46.000000
Institute Sold Previous 3 Months 9,451,158
Insider Holdings Date 2016-07-31
Insider Bought Previous 3 Months 212,625
Insider Holdings Percent 2.10%
Insider Sold Previous 3 Months 10,127
Insiders Shares Owned -
Price Change
7 Day Price Change $-
7 Day Percent Change -
21 Day Price Change $0.0300002
21 Day Percent Change 1.27%
30 Day Price Change $0.0200002
30 Day Percent Change 0.84%
Month To Date Price Change $-
Month To Date Percent -
90 Day Price Change $1.270000
90 Day Percent Change 113.39%
Quarter To Date $1.476300
Quarter To Date Percent 161.57%
180 Day Price Change $0.720000
180 Day Percent Change 43.11%
200 Day Price Change $0.900000
200 Day Percent Change 60.40%
Year To Date $0.750000
Year To Date Percent 45.73%
Profile
Description Sequenom Inc was incorporated in 1994 under the laws of the State of Delaware. It is a life science company providing revolutionary genomic and genetic analysis solutions for the molecular diagnostic and clinical research markets. It develop and commercialize molecular diagnostics testing services that target and serve molecular diagnostics markets, and also develop and commercialize research use genetic analysis products and services that target and serve discovery and clinical research markets. It offers its services and products in the United States and international emphasis in countries like European and Asia-Pacific regions. The Company operates in two operating segments; Sequenom Laboratories and Sequenom Bioscience. Sequenom Laboratories provides molecular based, laboratory developed tests, or LDTs, with a focus principally on prenatal diseases and conditions and ophthalmological diseases and conditions.
Details
Issue Type CS
Market Cap $284,991,623
Sec Type EQS
Auditor KPMG LLP
Total Shares Outstanding -
CEO Dirk Van Den Boom
Employees 434
Last Audit UQ
Classification
CIK 0001076481
Industry Biotechnology
Sector Healthcare
NAICS Research and Development in Biotechnology (except Nanobiotechnology)(541714)
Info
Address 3595 John Hopkins Court
San Diego, CA 92121
Website http://www.sequenom.com
Facisimile +1 858 202-9001
Telephone +1 858 202-9000
Email investorrelations@sequenom.com
Key Ratios
Profitability
EBIT Margin -28.8
EBITDA Margin -21.9
Pre-Tax Profit Margin -101.3
Profit Margin Cont -36.1
Gross Margin 46.20
Profit Margin TOT -36.1
Income Statements
Revenue $114,567,000
Revenue Per Share $0.9608
Revenue 3 Years $-5.85
Revenue 5 Years $19.73
Valuation Measures
PE Ratio -
Enterprise Value $351,466,623
Price To Sales 2.487554
Price To Free Cash -10.1
PE High Last 5 Years -
Price To Book 21.7
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book -4
Financial Strength
Total Debt To Equity -
Int Coverage -4.1
Current Ratio 3.4
Leverage Ratio -2.6
Quick Ratio 3.1
Long Term Debt To Capital -
Assets
Receivables Turnover 6.3
Invoice Turnover 15.80
Assets Turnover 0.30
Management Effectiveness
Return Assets -35.36
Return On Equity 109.52
Return On Capital -
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
SQNM
Sequenom, ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.